Drug Used in Pregnancies in 1960s, ’70s May Be Tied to Colon Cancers Today
TUESDAY, March 14, 2023 (HealthDay News) — The children of women who took a common anti-nausea drug for pregnancy in the 1960s and 1970s may be at higher risk of colon cancer, according to a new study.The drug, dicyclomine, is used to treat spasms ca…
Learn MoreLong-Term Study Supports ‘Watch and Wait’ for Most Prostate Cancers
MONDAY, March 13, 2023 (HealthDay News) — A man with prostate cancer who takes the “watch-and-wait” approach has the same long-term survival odds as those who undergo radiation therapy or surgery, according to a new large-scale study.Patients had the…
Learn MoreGemcitabine, Docetaxel a Viable Alternative to BCG in Bladder Cancer
MONDAY, March 13, 2023 (HealthDay News) — For patients with non-muscle invasive bladder cancer (NMIBC), gemcitabine and docetaxel therapy is associated with less high-grade disease recurrence, according to a study published online Feb. 28 in JAMA Net…
Learn MoreLow Prostate Cancer-Specific Mortality Seen for Men With Localized Disease
MONDAY, March 13, 2023 (HealthDay News) — For men with localized prostate cancer, prostate cancer-specific mortality is low at 15-year follow-up, regardless of treatment assigned, according to a study published online March 11 in the New England Jour…
Learn MoreBenefits Persist for Lenvatinib, Pembrolizumab in Renal Cell Cancer
MONDAY, March 13, 2023 (HealthDay News) — For patients with advanced renal cell carcinoma, progression-free survival and overall survival are improved with lenvatinib plus pembrolizumab versus sunitinib, according to a study published in the March is…
Learn MoreDos dietas saludables podrían reducir las ‘placas’ cerebrales vinculadas con el riesgo de Alzheimer
JUEVES, 9 de marzo de 2023 (HealthDay News) — Los adultos mayores que comen bastante verduras de hojas, pescado y otros alimentos saludables quizá reduzcan años de su “edad cerebral”, sugiere un nuevo estudio.Los investigadores encontraron que los ad…
Learn MoreInsurance Status Mediates Racial, Ethnic Inequities in Cervical Cancer
FRIDAY, March 10, 2023 (HealthDay News) — Insurance status mediates racial and ethnic inequities in advanced-stage cervical cancer diagnosis, according to a study published online March 10 in JAMA Network Open.Hunter K. Holt, M.D., from the Universit…
Learn MoreFDA Expands Indication for Use of Abemaciclib With Early, High-Risk Breast Cancer
FRIDAY, March 10, 2023 (HealthDay News) — Abemaciclib (Verzenio) with endocrine therapy (tamoxifen or an aromatase inhibitor) is now approved for the adjuvant treatment of adult patients with hormone receptor-positive, human epidermal growth factor r…
Learn MoreNeoadjuvant, Adjuvant Pembrolizumab Beneficial in Resectable Melanoma
FRIDAY, March 10, 2023 (HealthDay News) — For patients with resectable stage III or IV melanoma, event-free survival is longer for those receiving neoadjuvant and adjuvant pembrolizumab compared with those receiving only adjuvant pembrolizumab, accor…
Learn MoreMammogram Centers Must Notify Patients of Breast Density, FDA Says
THURSDAY, March 9, 2023 (HealthDay News) — New U.S. federal regulations will require mammography facilities to tell women if they have dense breasts. The U.S. Food and Drug Administration update amends regulations issued under the Mammography Quality…
Learn More